VPR Management’s Pfizer PFE Stock Holding History

VPR Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41K	Hold	100	–	–	﹤0.01%	66
2026 Q1	$2.81K	Hold	100	–	–	﹤0.01%	65
2025 Q4	$2.49K	Buy	+100	New	+$2.52K	﹤0.01%	63

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

VPR Management's PFE Position: Q2 2026 in Review

VPR Management held its Pfizer (PFE) position steady in Q2 2026 at 100 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #66.

VPR Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.81K in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

VPR Management held 100 shares of Pfizer worth $2.41K as of Q2 2026.
VPR Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of VPR Management's portfolio in Q2 2026, its #66 holding.
VPR Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
VPR Management's Pfizer position peaked at $2.81K in Q1 2026.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on VPR Management's 13F filing for Q2 2026, filed 14 Aug 2026.